| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vera Therapeutics, Inc. (VERA) has 18 insiders with recent SEC Form 4 filings, including 12 buys and 5 sells. VERA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 137.5K | $4.98M | - | |
| Other | 53.1K | $1.92M | - | |
| Other | 50.0K | $1.81M | - | |
| CFO | 50.0K | $1.81M | - | |
| Other | 49.1K | $1.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Seidenberg Beth C75 | Director | Buy | 23,478 | $7.24 | $170,047.18 | +0.7% | +15.3% | +578.7% | |
| Feb 23, 2023 | Seidenberg Beth C75 | Director | Buy | 200 | $7.24 | $1,447.00 | - | -0.5% | +526.8% | |
| Feb 13, 2023 | Seidenberg Beth C75 | Director | Buy | 10,072 | $7.20 | $72,490.20 | +0.6% | +6.3% | +475.6% | |
| Feb 9, 2023 | Seidenberg Beth C75 | Director | Buy | 400 | $7.25 | $2,900.00 | - | +5.8% | +493.5% | |
| Feb 8, 2023 | Seidenberg Beth C75 | Director | Buy | 311,078 | $7.10 | $2,209,588.20 | +5.3% | +5.5% | +418.8% | |
| Feb 6, 2023 | Longitude Capital Partners Iv, LLC63 | 10% Owner | Buy | 1,714,285 | $7.00 | $11,999,995.00 | New | +8.5% | +445.9% | |
| Feb 6, 2023 | Enright Patrick G74 | Director, 10% Owner | Buy | 1,714,285 | $7.00 | $11,999,995.00 | New | +8.5% | +445.9% | |
| Feb 6, 2023 | Sofinnova Venture Partners X, L.P.55 | 10% Owner | Buy | 285,714 | $7.00 | $1,999,998.00 | +9.0% | +8.5% | +445.9% | |
| Dec 16, 2022 | Curley Joanne69 | Chief Development Officer | Sale+OE | 2,212 | $19.49 | $43,115.93 | -4.0% | -64.6% | -22.0% | |
| Dec 13, 2022 | Curley Joanne69 | Chief Development Officer | Sale+OE | 19,711 | $18.26 | $359,972.96 | -19.7% | -62.3% | -25.7% |